Dr. Abinish D.G

Dr. Abinish D.G

Clinical Research Coordinator

SRM Medical College Hospital and Research Center

Profile ID RP-002-9497 Joined 2024-10-11 10 articles
0Connections
3
Total Views
10
Total Publications
317
Publication Views

Articles(10)

Authors: T. Amul Prathap, D. Lokeshvaran, D. G. Abinish, S. Kalaivani, J. Aswin

DOI: 10.18203/issn.2455-4529.intjresdermatol20250438

Volume11
Issue2
Pages167-170
Abstract

Fixed drug eruption is a rare but significant adverse drug reaction characterized by recurrent, well-defined skin lesions that consistently reappear at the same anatomical sites upon re-exposure to the offending drug. This case report presents a 48-year-old female who developed hyperpigmented patches on her left thigh and axilla followed by the administration of linezolid, an antibiotic used for treating resistant gram-positive bacterial infections. Although Linezolid is generally well-tolerated, it can cause cutaneous reactions, with fixed drug eruptions being an exceedingly rare occurrence. The patient's condition improved significantly after discontinuation of linezolid and treatment with corticosteroids, antihistamines, and topical agents. This case underscores the importance for clinicians to consider FDE in the differential diagnosis of patients receiving linezolid, particularly when lesions appear in atypical locations such as the thigh and axilla. Additionally, it emphasizes the critical role of prompt drug cessation and appropriate symptomatic treatment in managing such adverse reactions, thereby improving patient outcomes and ensuring better clinical management.

Authors: Abinish Dyneese Geetha, Rajavarma Paquirissamy, Aswin John, Kalaivani Sivakumar, Lokeshvaran Deivendran

DOI: 10.18231/j.ijoas.2024.021

Volume7
Issue4
Pages83-87
Abstract

Endoscopic dacryocystorhinostomy (DCR) is a surgical remedy for nasolacrimal duct obstructions (NLDO), addressing symptoms like excessive tear secretion and swelling. This article presents an observational case report of a 60-year-old female with persistent tear secretion and a non-healing ulcer below the left medial canthus at the previously operated external DCR site, managed initially with antibiotics and secondarily with closure of the external wound. Endoscopic DCR was subsequently performed under local anesthesia, effectively resolving symptoms and facilitating recovery. Advantages of endoscopic over external DCR include no external scar, lower infection rates, and faster recovery. Imaging aids in precise anatomical assessment. The case underscores meticulous preoperative evaluation, surgical precision, and comprehensive postoperative care for optimal outcomes. In conclusion, endoscopic DCR proves pivotal in revising failed procedures, ensuring functional and aesthetic success in managing NLDO.

Authors: Abinish Dyneese Geetha, Dhanalakshmi Ramasamy, Yusuf Siddiq Jamal Ahamed, Thabassum Abdul Rahman Noori, Iniyavan Sahadevan, Haris Madhavan Natarajan, Dino Arockia Raj

DOI: 10.18231/j.ijpp.2024.035

Volume11
Issue4
Pages213-220
Abstract

The objective of this study was to analyse the price variations of Fixed Dose Combinations (FDCs) of oral antidiabetic agents in India to highlight the percentage price variations among different brands offering the same formulations of oral antidiabetic FDCs.Diabetes is a metabolic disorder requiring consistent medication for blood glucose control. The wide cost variation among antidiabetic agents affects patient access and adherence, underscoring the importance of evaluating price differences to support affordable, effective diabetes management.This analytical study was conducted from August to September 2024, reviewing prices of 118 formulations across 34 oral antidiabetic FDCs sourced from the National Pharmaceutical Pricing Authority’s (NPPA) ‘Pharma Sahi Daam’ a public database. FDCs produced by multiple manufacturers were included, excluding single manufacturers. Microsoft Excel 2021 was used throughout the analysis.Among two-drug combinations, the highest percentage cost variation was observed in glimepiride + metformin (2mg + 1000mg) as 15958.33% and the lowest variation was found with empagliflozin + metformin as 0%. For three-drug combinations, the highest price variation was founded in voglibose + metformin + glimepiride (0.3mg + 500mg + 1mg) as 209900% and the least price variation was found in dapagliflozin + linagliptin + metformin (10mg + 5mg + 500mg) as 0%. The highest brand availability was recorded for glimepiride + metformin with 447 brands, and the lowest for pioglitazone + vildagliptin and teneligliptin + dapagliflozin, with only 2 brands each.This study highlights significant price variations among oral antidiabetic FDCs in India, which can affect patient’s treatment adherence. These findings underscore the need for intervention by regulatory authorities to enforce stricter measures in the pharmaceutical market to manage these price variations.

Authors: T. Amul Prathap, D.G. Abinish, S. Kalaivani, D. Lokeshvaran, J. Aswin

DOI: 10.37506/385gxd65

Volume19
Issue1
Pages18-23
Abstract

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are serious, life-threatening conditions often triggered by drug reactions, characterized by widespread skin detachment and mucosal involvement. This case report describes a 29-year-old woman who developed Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis after receiving prophylactic acyclovir for suspected herpes. The patient initially presented with oral ulcers that rapidly progressed to widespread blisters, ulcers, and severe skin peeling. A thorough diagnostic evaluation, including skin biopsy and the Naranjo algorithm, identified acyclovir as the causative agent. The patient was managed in intensive care with intravenous methylprednisolone 500mg per day for 3 consecutive days as pulse therapy, antibiotics, and other supportive treatments. This case underscores the importance of early recognition, prompt discontinuation of the offending drug, and a multidisciplinary treatment approach. It also highlights the critical need for heightened awareness among healthcare professionals regarding the potential for severe adverse reactions with commonly used medications like acyclovir, to improve patient safety and outcomes.

Authors: K. Manimozhi, D. Lokeshvaran, P. Theesmi Bershani, J. Jayaseelan, D. G. Abinish

DOI: 10.18203/2394-6040.ijcmph20243654

Volume11
Issue12
Pages4849-4854
Abstract

Background: Diabetes is a group of disorders marked by chronic high blood sugar due to issues with insulin. It includes type 1, type 2, genetic and drug-induced types, and gestational diabetes. A serious complication of diabetes is diabetic foot ulcers (DFUs), caused by peripheral neuropathy, vascular problems, and infections, which can lead to severe outcomes like amputations. Methods: A prospective cohort observational study was conducted over six months at a tertiary care teaching hospital involving 163 diabetic patients with foot ulcers, aged 20 to 80. The study assessed knowledge, attitude, and practices (KAP) regarding DFUs using a translated KAP questionnaire. Ulcer grades were classified using the Wagner system. Data were collected on socio-demographic factors, disease-related factors, and practices related to foot care. Results: This study found most of the participants were under the age group of 41-50, with a higher prevalence of females, and predominantly had type 2 diabetes. Common co-morbidities included hypertension, eye issues, and cardiovascular disease. Ulcer grading showed that most patients had Wagner grade 2 ulcers. Many participants lacked awareness about diabetes-related foot risks. Although most were open to lifestyle changes, many had gaps in foot care, with few following recommended practices. Conclusions: The study highlights the importance of better patient education and counselling to manage diabetic foot ulcers effectively. Although participants had a positive attitude towards foot care, there were significant gaps in their knowledge and practices. Healthcare providers, including pharmacists, need to improve education and communication to address these issues and help prevent severe complications.

Authors: K. Manimozhi, D. G. Abinish, S. Kalaivani, J. Aswin, D. Lokeshvaran

DOI: 10.18203/2319-2003.ijbcp20243025

Volume13
Issue6
Pages799-804
Abstract

Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease with systemic complications, necessitating treatment to manage inflammation and prevent joint damage. In India, significant cost discrepancies exist among branded formulations of generic drugs, posing a financial burden on patients and impacting treatment adherence. This study focuses on cost differences of disease modifying anti rheumatic drugs (DMARDs) among Indian brands and advocating strict adherence to drug price control order (DPCO) rules and suggests scheduling non-scheduled drugs under DPCO. Methods: This observational study analysed the cost of 6 oral DMARDs across 16 tablet formulations using data from National Pharmaceutical Pricing Authority (NPPA) and DPCO ceiling prices 2024. Number of brands per formulation, cost ratios, percentage variations, and DPCO price violations was analysed. Statistical analysis was performed using Microsoft Excel Office 2021, and Zotero was utilized for managing references. Results: This study highlights significant price variations among DMARDs in the Indian market, with methotrexate 2.5mg exhibiting the highest cost ratio (1:3.63) and percentage cost variation (263.6%). Azathioprine 50mg has the most brands available (23), while sulfasalazine 500mg, sulfasalazine 1000mg, and tofacitinib 11mg are among the formulations with the fewest brands (3 each). Notably, sulfasalazine 500mg and hydroxychloroquine 200mg showed the most frequent instances of pricing violations above DPCO recommendations. Conclusions: Strict regulation for price control and monitoring should be implemented since the DPCO has not yet achieved its goal of enforcing price ceilings, and non-scheduled drugs should be included under DPCO regulations effectively to enhance adherence to RA therapy.

Authors: Sabina T, Chaarumathi A. S, Iniyavan S, Rajamoorthy S, Abinish D. G

DOI: 10.36106/gjra/0700175

Volume13
Issue9
Pages1-4
Abstract

Background: Ischemic heart disease is a critical global health issue characterized by inadequate blood supply to the myocardium, leading to an imbalance between oxygen supply and demand. This study aimed to analyze the prescription patterns of both cardiovascular and non-cardiovascular drugs among ischemic heart disease patients at a government medical college hospital in Tamil Nadu, India. Methods and Materials: This observational prospective study was conducted over six months, from April to September 2023, involving 100 patients aged 31 years and above. Data were collected during ward rounds and regular follow-ups and were analysed using Microsoft Excel 2021. Results: The study revealed that the majority of ischemic heart disease patients were aged 51 to 60 years and men had a higher predominance rate than women. The most frequently prescribed drug classes were antiplatelet agents (17.26%), antihypertensives (17%), antihyperlipidemic drugs (8.76%), anticoagulants (7.80%), and nitrates (7.18%). Additionally, noncardiovascular drugs were widely prescribed, with antacids (8.93%) and benzodiazepines (7.27%) being the most common. The prescription patterns largely adhered to established management guidelines, with a focus on antiplatelets, antihypertensives, and statins. The frequent use of non-cardiovascular drugs indicated the presence of comorbid conditions, such as gastroesophageal reux disease and anxiety. Conclusion: This study highlights the prescription patterns for ischemic heart disease and their adherence to standard management practices concluding that antiplatelets were the most commonly prescribed drugs. It also emphasizes the need for future research with larger populations and an assessment of clinical outcomes.

Authors: Abinish D.G

DOI: 10.18502/jppm.v10i3.20251

Volume10
Issue3
Pages55-62
Abstract

Background: This study aims to examine the cost variations of oralantidiabetic agents in India, highlighting the financial barriers that may impactpatient adherence and treatment efficacy. Methods: This analytical study was performed by analysing the prices of 18 oralantidiabetic drugs with 42 formulations. Data was collected from the NationalPharmaceutical Pricing Authority (NPPA) platform, focusing on single-drug tabletformulations. Price variations were assessed using cost ratios and percentagecost variations. Compliance with the Drug Price Control Order (DPCO) ceilingprices were also analysed. Results: The study revealed significant price variations among different brandsof the same drug, with voglibose 0.3 mg exhibiting the highest cost ratio(1:139.92) and percentage variation (13892.30%). Additionally, a notableproportion of brands exceeded the DPCO ceiling prices, particularly metformin1000 mg, where 9 out of 15 brands were non-compliant to the ceiling price. Conclusion: Despite the presence of a regulatory authority, substantial pricevariability among oral antidiabetic agents persists in India, potentially affectingpatient adherence and health outcomes. The violations of DPCO pricingregulations indicate a need for stricter enforcement and expansion of pricecontrols to ensure the affordability of essential medications and improve overallpatient care.

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

BG
Bhupendra Gupta
0 publications
RN
Raveena Nagaram
0 publications
SJ
Dr Shreya jain
0 publications
SR
Sharif Ratul Hassan
Northern University Bangladesh
0 publications
DN
DEEPTHY NAIR
0 publications
PS
parimala subramani
0 publications
SA
Sushma Acharya
0 publications
UG
UMER GULL KHAN
0 publications
AR
Ananta Raj Sharma
0 publications
SS
simran sunita gupta
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

10 Publications

0 Contributions

Nothing added yet.

Filter